发明名称 |
Method for treating hepatitis C |
摘要 |
A method of treating a patient infected with a hepatitis C virus to decrease the severity of the viral infection. The method comprises concomitantly administering over a given period of time to the patient a first component and a second component. The first component consists of a pharmaceutical composition containing as an active ingredient a pharmaceutically acceptable salt or prodrug of mycophenolic acid in a therapeutically effective amount to decrease the severity of the viral infection. The second component consists of an injection solution containing as an active ingredient interferon-alpha or pegylated interferon-alpha in a therapeutically effective amount to decrease the severity of the viral infection. The components are concomitantly administered over a period of time at least sufficient to reduce the amount of HCV-RNA present in the peripheral blood of said patient to less than 100 copies/ml at 24 weeks after the end of treatment.
|
申请公布号 |
US2001046957(A1) |
申请公布日期 |
2001.11.29 |
申请号 |
US20010885773 |
申请日期 |
2001.06.20 |
申请人 |
GRAVES MARY;PAPPAS STEPHEN C.;ZAHM FRIEDERIKE |
发明人 |
GRAVES MARY;PAPPAS STEPHEN C.;ZAHM FRIEDERIKE |
分类号 |
A61K9/08;A61K31/365;A61K38/21;A61K47/48;A61P1/16;A61P31/12;A61P31/14;A61P43/00;(IPC1-7):A61K38/00;A01N37/18 |
主分类号 |
A61K9/08 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|